Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

639
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
639

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ultra-hypofractionated whole breast irradiation in early-stage breast cancer: an Italian multi-centre observational study.

International journal of radiation oncology, biology, physics·2026
Same author

SBRT plus abiraterone acetate and ADT versus abiraterone acetate and ADT in oligometastatic castrate-resistant prostate cancer (ARTO): long-term, unplanned overall survival analysis of an open-label, randomised, phase 2 trial.

The Lancet. Oncology·2026
Same author

Deciphering macrophage molecular responses to <i>Porphyromonas gingivalis</i> outer membrane vesicles through combined immunoassay and Raman spectroscopic analyses.

Frontiers in microbiology·2026
Same author

Impact of PSMA-Based Radiopharmaceuticals on the Clinical Management of Prostate Cancer.

Cancers·2026
Same author

Imaging Modality and Outcomes of Metastasis-Directed Therapy in Oligometastatic Castration-Resistant Prostate Cancer: An Updated Analysis of the PRECISE-MDT Cohort.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same author

Characterization of Plan Complexity and Its Role in Quality Assurance for AI-Assisted CBCT-Based Online Adaptive Radiotherapy of Prostate Cancer.

Cancers·2026

Related Experiment Video

Updated: Jan 12, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

636

Clinical Outcomes and Predictive Factors in NSCLC after Surgery: Findings from the RAC-TAC Study.

Alessio Bruni1, Davide Franceschini2, Beatrice Marini2

  • 1Radiotherapy Unit, Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy.

Clinical Lung Cancer
|November 1, 2025
PubMed
Summary

Postoperative radiation therapy (PORT) for non-small cell lung cancer (NSCLC) with pN2 disease shows that lymph node dissection extent and positive node count significantly impact recurrence. Distant metastases are the primary recurrence type, suggesting integrated therapies are needed.

Keywords:
BiomarkersNon small cell lung cancerPORTPost-operative radiotherapyPrecision medicineRadiotherapy

More Related Videos

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

482
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

10.2K

Related Experiment Videos

Last Updated: Jan 12, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

636
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

482
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

10.2K

Area of Science:

  • Oncology
  • Radiation Oncology
  • Thoracic Surgery

Background:

  • Recent trials (LUNG-ART, PORT-C) have updated postoperative radiation therapy (PORT) protocols for pN2 non-small cell lung cancer (NSCLC).
  • Assessing contemporary PORT techniques' toxicity and prognostic factors is crucial for optimizing patient outcomes.
  • Multicenter studies are essential for robustly evaluating clinical variables in NSCLC treatment.

Purpose of the Study:

  • To evaluate acute and long-term toxicities of modern PORT techniques in pN2 NSCLC.
  • To identify clinical factors influencing local control, distant control, and overall survival after PORT.
  • To develop a risk stratification system for pN2 NSCLC patients undergoing PORT.

Main Methods:

  • A multicenter observational study involving 6 Italian centers from 2015-2020.
  • Analysis of clinical data from NSCLC patients who received PORT.
  • Correlation of clinical variables with local recurrence, distant recurrence, and survival outcomes.

Main Results:

  • Local recurrence was associated with lymph node count and patient age.
  • Distant recurrence correlated with the number of positive lymph nodes and T stage.
  • Overall survival was linked to positive lymph node count and ECOG performance status, with a risk stratification system showing significant survival differences.

Conclusions:

  • Distant metastases are the predominant recurrence pattern in pN2 NSCLC post-PORT.
  • The extent of lymph node dissection and the number of positive nodes are key determinants of recurrence.
  • Integrating systemic and local therapies may improve outcomes for pN2 NSCLC patients.